Robert‐Jan Hassing
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Vibrio bacteria research studies
Papers in
-
- COVID-19 Clinical Research Studies 4
- Antimicrobial Resistance in Staphylococcus 3
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Perry J.J. van Genderen (7 shared papers)Annelies Verbon (5 shared papers)Wil H. F. Goessens (4 shared papers)Wilfrid van Pelt (2 shared papers)Dik Mevius (2 shared papers)Bruno H. Stricker (2 shared papers)Hugues Tolou (1 shared paper)Gerard van Doornum (1 shared paper)
- Journals
- Journal of Travel Medicine (4 papers)Clinical Infectious Diseases (3 papers)International Journal of Antimicrobial Agents (2 papers)AIDS Research and Human Retroviruses (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
- Partner nations
- NetherlandsFranceIndia
In The Last Decade
Robert‐Jan Hassing
24 papers receiving 306 citations
Peers
Comparison fields: 5 of 62
- Molecular Medicine 62
- Endocrinology 51
- Infectious Diseases 156
- Food Science 88
- Clinical Biochemistry 19
Countries citing papers authored by Robert‐Jan Hassing
This map shows the geographic impact of Robert‐Jan Hassing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert‐Jan Hassing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert‐Jan Hassing more than expected).
Fields of papers citing papers by Robert‐Jan Hassing
This network shows the impact of papers produced by Robert‐Jan Hassing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert‐Jan Hassing. The network helps show where Robert‐Jan Hassing may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert‐Jan Hassing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 53 | |
| 2 | 2014 | 44 | |
| 3 | 2013 | 31 | |
| 4 | 2019 | 27 | |
| 5 | 2016 | 26 | |
| 6 | 2011 | 23 | |
| 7 | 2021 | 19 | |
| 8 | 2021 | 13 | |
| 9 | 2016 | 11 | |
| 10 | 2024 | 10 | |
| 11 | 2012 | 10 | |
| 12 | 2018 | 9 | |
| 13 | 2022 | 7 | |
| 14 | 2010 | 6 | |
| 15 | 2012 | 6 | |
| 16 | IgG4-related disease: a disease we probably often overlook. | 2017 | 4 |
| 17 | 2019 | 3 | |
| 18 | 2018 | 3 | |
| 19 | 2008 | 2 | |
| 20 | 2020 | 2 |
About Robert‐Jan Hassing
Robert‐Jan Hassing is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Molecular Medicine and Food Science, having authored 26 papers that have together received 314 indexed citations. Recurring topics across this work include Salmonella and Campylobacter epidemiology (5 papers), Antibiotic Resistance in Bacteria (5 papers), COVID-19 Clinical Research Studies (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Mosquito-borne diseases and control (3 papers), Long-Term Effects of COVID-19 (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Molecular Medicine (62 citations), Endocrinology (51 citations), Infectious Diseases (156 citations), Food Science (88 citations) and Clinical Biochemistry (19 citations). Robert‐Jan Hassing has collaborated with scholars based in Netherlands, France and India. Frequent co-authors include Perry J.J. van Genderen, Annelies Verbon, Wil H. F. Goessens, Wilfrid van Pelt, Dik Mevius, Bruno H. Stricker, Hugues Tolou, Gerard van Doornum, Isabelle Leparc-Goffart and Bruno H. Stricker. Their work appears in journals such as Journal of Travel Medicine, Clinical Infectious Diseases, International Journal of Antimicrobial Agents, AIDS Research and Human Retroviruses and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.